CCR5 Δ32 deletion and reduced risk of toxoplasmosis in persons infected with human immunodeficiency virus type 1

Journal of Infectious Diseases

Volumn 180, Issue 3, 1999, Pages 920-924

  Meyer, Laurence ^a   Magierowska, Magda ^b   Hubert, Jean Baptiste ^a   Mayaux, Marie Jeanne ^a   Misrahi, Micheline ^a   Le Chenadec, Jérôme ^a   Debre, Patrice ^b   Rouzioux, Christine ^c   Delfraissy, Jean François ^a   Theodorou, Ioannis ^b  

^a BICÊTRE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; GENE DELETION; HERPES VIRUS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TOXOPLASMOSIS; WASTING SYNDROME; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COHORT ANALYSIS; FOLLOW UP; GENETICS; IMMUNOLOGY; MULTICENTER STUDY; RISK FACTOR; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CCR5; RISK FACTORS; SEQUENCE DELETION; TIME FACTORS; TOXOPLASMOSIS;

EID: 0032825568     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314933     Document Type: Article

References (15)

1. 1. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
2. + cells is mediated by the chemokine receptor CC-CKR-5, Nature 1996;381:667-73.
3. 3. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
4. 4. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-62.
5. 5. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C, and SEROCO Study Group. HIV-1 infection in an individual homozygous for CCR5 Δ32. Lancet 1997;349:1219-20.
6. 6. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR-5 Δ32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997;11:73-8.
7. 7. de Roda Husman AM, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997;127:882-90.
8. 8. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;7:436-45.
9. 9. Boufassa F, Carré N, Deveau C, et al. HEMOCO: a French prospective study of hemophiliacs infected by HIV-1. Hematol Cell Ther 1996;38:193-8.
10. 10. Misrahi M, Teglas JP, N'Go N, et al. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. JAMA 1998;279:277-80.
11. 11. Belanger F, Derouin F, Grangeot-Keros L, Meyer L. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988 1995. HEMOCO and SEROCO Study Groups. Clin Infect Dis 1999;28:575-81.
12. 12. Hunter CA, Remington JS. Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis 1994;170:1057-67.
13. 13. Suzuki Y, Wong SY, Grumet FC, et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J Infect Dis 1996;173:265-8.
14. 14. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type I T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
15. 15. Zhou Y, Kurihara T, Ryseck RP, et al. Impaired macrophage function and enhanced T cell dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 1998;160: 4018-25.